tiprankstipranks
Clearone Communications Inc. (CLRO)
NASDAQ:CLRO
US Market
Want to see CLRO full AI Analyst Report?

Clearone Communications (CLRO) AI Stock Analysis

250 Followers

Top Page

CLRO

Clearone Communications

(NASDAQ:CLRO)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
$4.00
▼(-23.08% Downside)
Action:Reiterated
Date:07/26/26
The score is primarily weighed down by weak financial performance—negative TTM revenue, expanding losses, sustained cash burn, and an impaired equity position that elevates financial risk. Technicals are only modestly supportive (positive MACD and above key longer-term averages) but near-term weakness persists. Valuation is also constrained by a negative P/E and lack of dividend support.
Positive Factors
Strategic pivot into neurostimulation
The planned Cortigent merger repositions the company from legacy AV into a higher‑growth neurostimulation/medical device market, brings Vivani’s expertise and capital, and installs new governance. That structural shift can create new long‑term revenue and R&D pathways beyond AV cycles.
Negative Factors
Revenue and profitability collapse
A sharp multi‑year revenue decline and persistent operating losses indicate the core AV business no longer covers fixed costs. Without new, durable revenue streams, margin recovery will be difficult and the company faces structural viability risks until the business is meaningfully reconstituted.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic pivot into neurostimulation
The planned Cortigent merger repositions the company from legacy AV into a higher‑growth neurostimulation/medical device market, brings Vivani’s expertise and capital, and installs new governance. That structural shift can create new long‑term revenue and R&D pathways beyond AV cycles.
Read all positive factors

Clearone Communications (CLRO) vs. SPDR S&P 500 ETF (SPY)

Clearone Communications Business Overview & Revenue Model

Company Description
ClearOne, Inc., established in 1983 and headquartered in Salt Lake City, Utah, specializes in the design, development, and sale of advanced communication solutions. The company provides a comprehensive suite of conferencing, collaboration, and net...
How the Company Makes Money
ClearOne primarily makes money by selling professional audio/visual communications hardware and related solutions to customers through distribution and reseller/integrator channels (e.g., professional AV dealers and systems integrators) and, where...

Clearone Communications Financial Statement Overview

Summary
Financial performance is highly stressed: TTM revenue turned negative, losses have expanded materially, and operating/net results remain persistently weak. Cash flow is also deeply negative (ongoing cash burn), and equity has compressed to near-zero with negative equity flagged in 2025—raising solvency and liquidity risk despite low nominal debt.
Income Statement
9
Very Negative
Balance Sheet
28
Negative
Cash Flow
12
Very Negative
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue0.0011.39M18.70M25.20M28.97M
Gross Profit-328.00K2.63M6.36M9.46M11.92M
EBITDA-4.26M-7.93M1.56M31.25M-4.19M
Net Income-26.08M-8.98M-560.00K20.56M-7.69M
Balance Sheet
Total Assets2.30M26.54M50.69M83.75M66.19M
Cash, Cash Equivalents and Short-Term Investments220.00K1.42M21.32M984.00K2.86M
Total Debt513.00K771.00K1.05M4.87M6.67M
Total Liabilities3.01M5.21M6.01M9.62M14.69M
Stockholders Equity-714.00K21.33M44.69M74.13M51.50M
Cash Flow
Free Cash Flow-7.52M-6.31M54.25M-4.23M-4.62M
Operating Cash Flow-7.52M-6.12M54.63M-4.18M-4.39M
Investing Cash Flow2.91M4.19M-4.88M2.08M-8.51M
Financing Cash Flow3.97M-14.47M-32.89M2.05M10.21M

Clearone Communications Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.20
Price Trends
50DMA
4.83
Negative
100DMA
4.18
Negative
200DMA
4.85
Negative
Market Momentum
MACD
0.46
Positive
RSI
46.47
Neutral
STOCH
6.98
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CLRO, the sentiment is Negative. The current price of 5.2 is below the 20-day moving average (MA) of 6.94, above the 50-day MA of 4.83, and above the 200-day MA of 4.85, indicating a bearish trend. The MACD of 0.46 indicates Positive momentum. The RSI at 46.47 is Neutral, neither overbought nor oversold. The STOCH value of 6.98 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CLRO.

Clearone Communications Risk Analysis

Clearone Communications disclosed 19 risk factors in its most recent earnings report. Clearone Communications reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Clearone Communications Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$457.17B38.4125.14%1.45%9.21%25.97%
62
Neutral
$33.68B35.72101.45%0.59%33.34%71.52%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
$242.84M38.214.01%4.18%2.02%-56.43%
55
Neutral
$239.99M-32.23-8.79%-17.17%23.08%
53
Neutral
$648.45M-17.26-7.97%3.66%-200.01%
44
Neutral
$10.92M-0.31-520.98%-80.99%-113.71%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CLRO
Clearone Communications
4.08
-0.68
-14.29%
AUDC
Audiocodes
9.58
0.05
0.51%
CSCO
Cisco Systems
115.99
48.89
72.86%
LTRX
Lantronix
5.38
2.28
73.55%
NTGR
Netgear
24.16
0.47
1.98%
UI
Ubiquiti Networks
556.52
120.98
27.78%

Clearone Communications Corporate Events

Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesM&A TransactionsPrivate Placements and Financing
ClearOne to Merge with Cortigent, Pivoting to Neurotech
Neutral
Jul 6, 2026
On July 1, 2026, ClearOne agreed to merge Cortigent, a Vivani Medical subsidiary developing precision neurostimulation implants, into a wholly owned ClearOne subsidiary, with Vivani receiving 12.5 million ClearOne shares and becoming majority owne...
Business Operations and StrategyPrivate Placements and Financing
ClearOne Secures New $1 Million Working Capital Loan
Neutral
Jul 1, 2026
On June 30, 2026, ClearOne, Inc. entered into a loan agreement with First Finance Ltd. for up to $1 million in financing, structured in tranches with an initial $500,000 draw and additional $250,000 tranches at mutually agreed dates. The loan carr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 26, 2026